Interleukin Enhancer Binding Factor 2, 45kDa (ILF2) ELISA Kits

The protein encoded by ILF2 is the 45 kDa component of nuclear factor of activated T-cells (NFAT), a heterodimer of 45 kDa and 90 kDa proteins. Zusätzlich bieten wir Ihnen ILF2 Antikörper (126) und ILF2 Proteine (10) und viele weitere Produktgruppen zu diesem Protein an.

list all ELISA KIts Gen GeneID UniProt
ILF2 3608 Q12905
ILF2 67781 Q9CXY6
ILF2 310612 Q7TP98
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen

Top ILF2 ELISA Kits auf

Showing 4 out of 4 products:

Katalog Nr. Reaktivität Sensitivität Bereich Bilder Menge Lieferzeit Preis Details
  96 Tests 15 bis 18 Tage
  96 Tests 15 bis 18 Tage
  96 Tests 15 bis 18 Tage
  10 reactions 4 bis 6 Tage

Weitere ELISA Kits für ILF2 Interaktionspartner

Pig (Porcine) Interleukin Enhancer Binding Factor 2, 45kDa (ILF2) Interaktionspartner

  1. These findings are the first to confirm that the porcine ILF2 interacts with the nsp9 and nsp2 of porcine reproductive and respiratory syndrome virus in vitro, and exerts negative regulatory effect on the replication of the virus.

Human Interleukin Enhancer Binding Factor 2, 45kDa (ILF2) Interaktionspartner

  1. Taken together, these results suggest that DANCR acts as a prognostic biomarker and increases HIF-1alpha mRNA stability by interacting with NF90/NF45, leading to metastasis and disease progression of nasopharyngeal carcinoma.

  2. this study identifies a new role of ILF2 in the regulation of the NLRP3 inflammasome.

  3. High expression of ILF2 was tightly correlated with lymph node metastasis, pathological stage and poor clinical prognosis in gastric cancer.

  4. ILF2 interacts with RNA-binding proteins involved in the DNA damage response.

  5. The data suggest that features of both the N- and C-termini of NF90 participate in the heterodimerization with NF45 and that the formation of NF90-NF45 changes the conformation of NF90's RNA-binding motifs to a status in which the co-operative interplay of the RNA-binding motifs is optimal.

  6. NF90-NF45 stimulates an elevation of EGF receptor levels via the suppression of miR-7 biogenesis, resulting in the promotion of cell proliferation in Hepatocellular Carcinoma.

  7. The results revealed that ILF2 is regulated by miR-7 and suggest that downregulation of miR-7 may be an important factor for the ILF2 overexpression in pancreatic carcinoma.

  8. Deletion of the RNA binding domains of NF45 and NF90 diminished the enhancement of HIV infection and gene expression.

  9. NF45 overexpression is associated with poor prognosis and enhanced cell proliferation of pancreatic ductal adenocarcinoma.

  10. Upregulated expression of ILF2 in non-small cell lung cancer is associated with tumor cell proliferation and poor prognosis

  11. The RNA binding complexes NF45-NF90 and NF45-NF110 associate dynamically with the c-fos gene and function as transcriptional coactivators.

  12. NF45 and NF90 are novel higher-eukaryote-specific factors required for the maturation of 60S ribosomal subunits.

  13. These findings suggested that NF45 might play an important role in promoting the tumorigenesis of ESCC, and thus be a promising therapeutic target to prevent ESCC progression.

  14. These results suggest a novel molecular mechanism for the modulation of RNA granule assembly and disassembly by NFAR2, NF45, and phosphorylation at double-stranded RNA-activated kinase PKR sites.

  15. These findings indicate that NF45 plays an important role in the growth regulation of glioma cells

  16. AU-rich 5' UTRs harboring internal ribosome entry sites are regulated by NF45. NF45 regulates XIAP protein levels through interaction with its IRES.

  17. The NF90/NF45 complex participates in DNA break repair via nonhomologous end joining

  18. spatial interactions of hnRNPH1, NF45, and C14orf166 with HCVc174 likely modulate HCV or cellular functions during acute and chronic HCV infection

  19. ILF2 recruits a DNA-associated replication and transcription complex, of which it is a part, to its target DNA sequence.

  20. The data presented are consistent with a model in which translation of cIAP1 is governed, at least in part, by NF45, a novel cellular IRES trans-acting factor.

Mouse (Murine) Interleukin Enhancer Binding Factor 2, 45kDa (ILF2) Interaktionspartner

  1. Data support a model in which NF45, NF90, and NF110 operate in feedback loops that enable them, through both overlapping and independent targets, to help balance the push and pull of pluripotency and differentiation cues.

  2. NF90-NF45 complex induces centronuclear myopathy through increased dynamin 2 expression by an NF90-NF45-induced reduction of miR-133a expression in vivo.

  3. Ilf2 is regulated during meiosis and associated to transcriptionally active chromatin

  4. we propose that NF45 and NF90 have the potential to activate SP-10 gene transcription, and that a chromatin modification event must occur first in order to provide access to these transcription factors.

ILF2 Antigen-Profil

Beschreibung des Gens

The protein encoded by this gene is the 45 kDa component of nuclear factor of activated T-cells (NFAT), a heterodimer of 45 kDa and 90 kDa proteins. NFAT is a transcription factor required for T-cell expression of the interleukin 2 gene. It also binds RNA and is an essential component for encapsidation and protein priming of hepatitis B viral polymerase. The complex has been shown to repair DNA breaks by nonhomologous end joining and can also negatively regulate the microRNA processing pathway. Alternative splicing results in multiple transcript variants. Related pseudogenes have been found on chromosomes 3 and 14.

Genbezeichner und Symbole assoziert mit ILF2

  • interleukin enhancer binding factor 2 (ilf2) Antikörper
  • interleukin enhancer binding factor 2 (ILF2) Antikörper
  • interleukin enhancer binding factor 2 L homeolog (ilf2.L) Antikörper
  • interleukin enhancer binding factor 2 (Ilf2) Antikörper
  • 6230405A16Rik Antikörper
  • ILF2 Antikörper
  • NF45 Antikörper
  • PRO3063 Antikörper
  • TEG-267 Antikörper
  • Tex261 Antikörper
  • Tex267 Antikörper
  • wu:fb34h01 Antikörper
  • zgc:73084 Antikörper
  • zgc:77276 Antikörper

Bezeichner auf Proteinebene für ILF2

interleukin enhancer binding factor 2, 45kDa , interleukin enhancer-binding factor 2 homolog , interleukin enhancer-binding factor 2-like , interleukin enhancer binding factor 2, 45kD , interleukin enhancer-binding factor 2 , nuclear factor of activated T-cells, 45-kDa , nuclear factor of activated T-cells 45 kDa , testis expressed gene 267 , liver regeneration-related protein LRRG031

394593 Xenopus (Silurana) tropicalis
425709 Gallus gallus
457328 Pan troglodytes
715452 Macaca mulatta
100056483 Equus caballus
100154734 Sus scrofa
100392270 Callithrix jacchus
406517 Danio rerio
380267 Xenopus laevis
3608 Homo sapiens
67781 Mus musculus
310612 Rattus norvegicus
480139 Canis lupus familiaris
539760 Bos taurus
100172468 Pongo abelii
Ausgewählte Anbieter für ILF2 (ILF2) ELISA Kits
Haben Sie etwas anderes gesucht?